Perge Kevin, Nicolino Marc
Service d'Endocrinologie Pédiatrique Et Pédiatrie Générale, Hospices Civils de Lyon, Hôpital Femme Mère Enfant, 59 Boulevard Pinel, 69677, Bron, France.
Université Claude Bernard, Lyon 1, 8 Avenue Rockefeller, 69008, Lyon, France.
Rev Endocr Metab Disord. 2022 Oct;23(5):1063-1078. doi: 10.1007/s11154-022-09749-2. Epub 2022 Aug 23.
Maturity-Onset Diabetes of the Youth (MODY) diabetes remains commonly misdiagnosed. A monogenic form should be suspected in individuals presenting hyperinsulinemic hypoglycemia (HH) associated with, either later development of MODY (hypoglycemia-remission-diabetes sequence), or with first/second-degree family history of diabetes. Herein, we aimed to describe this individual or family monogenic association between HH and diabetes, and identify potential genotype-phenotype correlations. We conducted a systematic review of 26 studies, including a total of 67 patients with this association resulting from variants in GCK (n = 5 cases), ABCC8 (n = 29), HNF1A (n = 5), or HNF4A (n = 28). A family history of hypoglycemia and/or diabetes was present in 91% of cases (61/67). Median age at first hypoglycemia was 24 h after birth. Diazoxide was initiated in 46 children (46/67-69%); responsiveness was found in 91% (42/46). Median HH duration was three years (1 day-25 years). Twenty-three patients (23/67-34%) later developed diabetes (median age: 13 years; range: 8-48); more frequently in those untreated with diazoxide. This association was most commonly inherited in an autosomal dominant manner (43/48-90%). Some genes were associated with less severe initial hypoglycemia (HNF1A), shorter duration of HH (HNF4A), and more maternal (ABCC8) or paternal (HNF4A) transmission. This study illustrates that the same genotype can give a biphasic phenotype in the same person or a reverse phenotype in the same family. Wider awareness of this association is necessary in pediatrics to establish annual monitoring of patients who have presented HH, and during maternity to screen diabetes and optimize genetic counseling and management of pregnancy, childbirth, and the newborn.PROSPERO registration: CRD42020178265.
青年发病的成年型糖尿病(MODY)常被误诊。对于出现高胰岛素血症性低血糖(HH)且伴有MODY后期发病(低血糖-缓解-糖尿病序列)或有糖尿病一级/二级家族史的个体,应怀疑为单基因形式。在此,我们旨在描述HH与糖尿病之间的个体或家族单基因关联,并确定潜在的基因型-表型相关性。我们对26项研究进行了系统综述,共纳入67例因GCK(n = 5例)、ABCC8(n = 29)、HNF1A(n = 5)或HNF4A(n = 28)基因变异导致这种关联的患者。91%(61/67)的病例有低血糖和/或糖尿病家族史。首次低血糖发作的中位年龄为出生后24小时。46名儿童(46/67,69%)开始使用二氮嗪治疗;91%(42/46)有反应。HH的中位病程为三年(1天至25年)。23例患者(23/67,34%)后来发展为糖尿病(中位年龄:13岁;范围:8至48岁);未接受二氮嗪治疗的患者更常见。这种关联最常见的遗传方式为常染色体显性遗传(43/48,90%)。一些基因与较轻的初始低血糖(HNF1A)、较短的HH病程(HNF4A)以及更多的母系(ABCC8)或父系(HNF4A)传递相关。本研究表明,相同的基因型在同一个体中可产生双相表型,或在同一家族中产生相反表型。儿科领域有必要更广泛地认识这种关联,以便对出现HH的患者进行年度监测,并在孕期筛查糖尿病,优化遗传咨询以及妊娠、分娩和新生儿的管理。PROSPERO注册号:CRD42020178265。